Alterations in non-insulin-mediated glucose uptake in the elderly patient with diabetes

被引:19
作者
Forbes, A
Elliott, T
Tildesley, H
Finegood, D
Meneilly, GS
机构
[1] Univ British Columbia, Div Geriatr Med, Vancouver, BC V5Z 1M9, Canada
[2] Univ British Columbia, Div Endocrinol, Vancouver, BC V5Z 1M9, Canada
[3] Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada
[4] Simon Fraser Univ, Sch Kinesiol, Vancouver, BC, Canada
关键词
D O I
10.2337/diabetes.47.12.1915
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It is increasingly recognized that alterations in non-insulin-mediated glucose uptake (NIMGU) play an important pathogenic role in disorders of carbohydrate metabolism. This study was conducted to determine whether NIMGU is impaired in elderly patients with type 2 diabetes. Healthy elderly control subjects (n = 19, age 76 +/- 1 years, BMI 26.8 +/- 1.1 kg/m(2)) and elderly patients with type 2 diabetes (n = 19, age 76 +/- 2 years, BMI 27.5 +/- 0.9 kg/m(2)) underwent a 240-min glucose clamp study. Octreotide was infused to suppress endogenous insulin release, and tritiated glucose methodology was used to measure glucose uptake and disposal rates. For the first 180 min, glucose was kept at fasting levels. From 180 to 240 min, glucose was increased to 11 mmol/l, At fasting glucose levels, glucose uptake was similar in both groups. However, glucose clearance was reduced in patients with diabetes (control 1.68 +/- 0.05 ml.kg(-1).min(-1); diabetes 1.34 +/- 0.07 ml.kg(-1).min(-1), P < 0.0001). During hyperglycemia, glucose uptake was reduced in patients with diabetes (control 3.16 +/- 0.09 mg.kg(-1).min(-1); diabetes 2.57 +/- 0.11 mg.kg(-1).min(-1), P < 0.0001). Peripheral glucose effectiveness (S-G) was less in patients with diabetes (control 1.28 +/- 0.04 ml.kg(-1).min(-1); diabetes 0.94 +/- 0.08 ml.kg(-1).min(-1), P < 0.0001). Hepatic glucose output and hepatic S-G were not different between groups. We conclude that the effect of glucose on glucose uptake is impaired in elderly patients with type 2 diabetes, a finding that may have therapeutic implications for this patient population.
引用
收藏
页码:1915 / 1919
页数:5
相关论文
共 50 条
[1]   ASSESSMENT OF INSULIN ACTION AND GLUCOSE EFFECTIVENESS IN DIABETIC AND NONDIABETIC HUMANS [J].
ALZAID, AA ;
DINNEEN, SF ;
TURK, DJ ;
CAUMO, A ;
COBELLI, C ;
RIZZA, RA .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (06) :2341-2348
[2]  
ANDRES R, 1966, AUTOMAT ANAL CHEM, P486
[3]   RATES OF NONINSULIN-MEDIATED GLUCOSE-UPTAKE ARE ELEVATED IN TYPE-II DIABETIC SUBJECTS [J].
BARON, AD ;
KOLTERMAN, OG ;
LAWRENCE, JB ;
MANDARINO, J ;
OLEFSKY, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (05) :1782-1788
[4]   RATES AND TISSUE SITES OF NON-INSULIN-MEDIATED AND INSULIN-MEDIATED GLUCOSE-UPTAKE IN HUMANS [J].
BARON, AD ;
BRECHTEL, G ;
WALLACE, P ;
EDELMAN, SV .
AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 255 (06) :E769-E774
[5]   Impaired basal glucose effectiveness in NIDDM - Contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol [J].
Basu, A ;
Caumo, A ;
Bettini, F ;
Gelisio, A ;
Alzaid, A ;
Cobelli, C ;
Rizza, RA .
DIABETES, 1997, 46 (03) :421-432
[6]   ASSESSMENT OF INSULIN SENSITIVITY INVIVO [J].
BERGMAN, RN ;
FINEGOOD, DT ;
ADER, M .
ENDOCRINE REVIEWS, 1985, 6 (01) :45-86
[7]  
BERGMAN RN, 1979, AM J PHYSIOL, V227, P1314
[8]   Role of glucose effectiveness in the determination of glucose tolerance [J].
Best, JD ;
Kahn, SE ;
Ader, M ;
Watanabe, RM ;
Ni, TC ;
Bergman, RN .
DIABETES CARE, 1996, 19 (09) :1018-1030
[9]   DIRECT EVIDENCE FOR A STIMULATORY EFFECT OF HYPERGLYCEMIA PER-SE ON PERIPHERAL GLUCOSE DISPOSAL IN TYPE-II DIABETES [J].
CAPALDO, B ;
SANTORO, D ;
RICCARDI, G ;
PERROTTI, N ;
SACCA, L .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (04) :1285-1290
[10]   PATHOGENESIS OF AGE-RELATED GLUCOSE-INTOLERANCE IN MAN - INSULIN RESISTANCE AND DECREASED BETA-CELL FUNCTION [J].
CHEN, M ;
BERGMAN, RN ;
PACINI, G ;
PORTE, D .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 60 (01) :13-20